Gyo Asai

Suggest Changes
Learn More
The aim of this study was to analyze the pharmacokinetics and pharmacodynamics (PK/PD) of 6-O-(3-ethoxypropionyl)-3′,4′-O-exo-benzylidene-chartreusin (IST-622) and its metabolites, and to develop(More)
7282 Background:COX-2 is overexpressed in NSCLC, and COX-2 promotes tumor growth through the production of prostaglandins (PGs). Meloxicam, a selective COX-2 inhibitor, inhibits the growth of COX-2(More)
  • 1